Description
Novel first-in-class MT2 melatonin receptor partial agonists for neuropathic pain
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02016-04-01$160,000
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2016-04-01(start date) | $160,000 | — | Novel first-in-class MT2 melatonin receptor partial agonists for neuropathic pain |
Related records · 5
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (exact legal name match; no business number on file)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 236-2026-2027-Q1-00969 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $684,675 | FY2027 |
| 236-2025-2026-Q4-00111 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $450,000 | FY2026 |
| 236-2020-2021-Q3-00460 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $784,126 | FY2021 |
| 236-2017-2018-Q1-00234 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $459,000 | FY2018 |
| 236-2016-2017-Q2-00320 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $100,000 | FY2017 |
Cite as: Glassbox record view · Federal grants & contributions · 236-2015-2016-Q4-00113 · retrieved 2026-11-14.